Probiotics for prevention of necrotising enterocolitis: an updated meta-analysis

F Guthmann1, C Kluthe, C Bührer

  • 1Klinik für Neonatologie, Charité Universitätsmedizin Berlin, Germany. florian.guthmann@charite.de

Klinische Padiatrie
|July 21, 2010
PubMed

Insights

Prophylactic probiotics significantly reduce necrotizing enterocolitis (NEC) and mortality in preterm infants. Studies show these beneficial bacteria are safe and effective for vulnerable newborns.

Area of Science:

  • Neonatal Medicine
  • Microbiology
  • Clinical Trials

Background:

  • Necrotizing enterocolitis (NEC) is a major cause of mortality in preterm infants.
  • Prophylactic probiotic use has been investigated to reduce NEC rates.
  • Previous meta-analyses exist, but recent trials offer updated insights.

Purpose of the Study:

  • To evaluate the efficacy and safety of prophylactic probiotics in preterm infants at risk for NEC.
  • To synthesize evidence from existing meta-analyses and recent randomized controlled trials (RCTs).
  • To determine the impact of probiotics on NEC incidence and mortality.

Main Methods:

  • Meta-analysis of multiple randomized controlled trials (RCTs) investigating prophylactic probiotic use.
  • Analysis of three subgroups: common RCTs, previously included RCTs, and recent RCTs.
  • Calculation of relative risk (RR) for NEC (Bell stage ≥2) and mortality.

Main Results:

  • Consistent reduction in NEC rates (RR 0.35) and mortality (RR 0.41) across all meta-analysis approaches.
  • NEC and mortality rates align with North American and European network data.
  • Optimal outcomes observed with multi-species probiotics, including Bifidobacterium spp. and Lactobacillus acidophilus.
  • No adverse side effects reported in 1,117 infants receiving probiotics.

Conclusions:

  • Prophylactic probiotics are safe and beneficial for preterm infants at risk of NEC.
  • The use of specific probiotic combinations may enhance efficacy.
  • Evidence supports the integration of probiotics into neonatal care protocols for NEC prevention.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...